Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat for weight loss maintenance in obese patients
NCT02706067Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2002
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of orlistat in obesity, sponsored by Roche. Primary endpoints: Percent Change from Baseline in Body Weight at Year 2 and Percent Change from Baseline in Body Weight at Year 4. Started Jul 2002; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02706067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706067.